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Prevention of Environmentally
Related Diseases
The National Institute ofEnvironmental Health Sciences is dedicated
to reducing human diseases through a multidisciplinary approach
focused on prevention ofenvironmentally related illnesses. A central
question is how best to focus our research and other activities to have
the greatest impact on human health. Current research activities at the
NIEHS are directed toward these goals, but improvements in certain
areas, together with an enhanced emphasis on environmentally rele-
vant diseases, can greatly expedite the achievement of our public
health mission.
A successful program for prevention ofenvironmentally related dis-
eases should havethree components that must beintegrative and interac-
tive: 1) identification ofenvironmental hazards, 2) elucidation ofmecha-
nisms ofenvironmental agents and environmentally related diseases, and
3) development and refinement ofrisk assessmentmethodologies.
The National Toxicology Program has unquestionably the world's
premier program for carcinogen identification. The NTP bioassay
should continue to be the cornerstone ofthe NIEHS program of pre-
vention ofenvironmentally related diseases by identifying agents that
have the potential to cause human cancer and other chronic disorders.
A question exists, however, about whether the program identifies the
major environmental causes ofhuman cancers. It is imperative to ask
whether the strategies used to select chemicals for NTP testing are the
most relevant and have the largest possible impact on the identifica-
tion of causes ofhuman cancer and other environmentally related dis-
eases. It would be interesting (ifit were possible) to estimate the total
number ofpotentially preventable human cancers attributable to the
carcinogens so far identified by the NTP; the number could be a very
small percentage of all cancers. Therefore, new principles should be
adopted to improve the selection ofchemicals and testing procedures.
Some examples ofthese principles are as follows.
* Exploit what is known. We should take advantage of the
advances in our knowledge about mechanisms of environmentally
related diseases that may allow more chemicals to be evaluated and
predicted (tested) by alternative means. Forexample, the role ofmuta-
genesis in carcinogenesis is clearly established; thus, there is little need
to continue to study mutagens in two-year carcinogenesis bioassays for
carcinogen identification. Even though some chemical mutagens are
inactive in the standard bioassay, these are potentially carcinogenic in
other contexts, and perhaps mutagens per se should receive greater
attention from regulatory agencies. Internationally accepted proce-
dures for mutagen evaluation in vitroand in vivoshould be more uni-
formly and widely adopted, and chemicals that are clearly positive
should be considered reasonably anticipated to be carcinogenic to
humans. This would allow evaluation of a larger number ofchemicals
by alternative, short-term tests. Alternative approaches to dose-
response relationships for risk assessment could be based on muta-
genic orpreneoplastic endpoints.
In addition, evaluation of chemicals by structure-activity relation-
ships is another alternative to the two-year bioassay (1). For thosedasses
ofchemicals where our knowledge is limited, bioassays should be per-
formed to test hypotheses related to structure-activity relationships.
Furthermore, where our knowledge is substantial, bioassays are not nec-
essary and certain chemicals or dasses ofchemicals should be assumed
to be carcinogenic to humans (e.g., nitrosamines, anthraquinones, and
benzidinecongeners) (2. The recent success ofTennantandco-workers
(1) in predicting the outcomes ofrodent carcinogenicity tests demon-
strates that alternative approaches to carcinogen identification are feasi-
ble. Although this approach is not possible with all chemicals, there are
certain chemicals and classes ofchemicals forwhich predictive toxicology
is possible basedon knowledgeofmechanisms ofaction. Additional alter-
natives to the two-year bioassay indude short- and mid-term in vivo
assays (3), transgenic animals (4), alternative species including aquatic
animals (5), andcell culture models (6). These arevaluable for evaluation
ofchemicals for noncancer as well as carcinogenic effects, for identifying
possible mechanisms, and for establishing priorities in the selection of
chemicals that should be tested in two-year bioassays. Another practical
consideration would be simply to reduce the size ofthe two-year studies
byusingonlymale rats and female mice and to adopt modified protocols
(2,1). This has been shown, in a retrospective evaluation ofstandard two-
species, both-sex studies, to have "correctly" identified 96% ofthe "posi-
tive" and"negative" studies (2,7,8). Theoretically, thiswould allowevalu-
ation ofnearlytwice as manychemicals with the same resources. Further,
expanded bioassays oftransgenerational carcinogenesis may be warranted
(19).
The NTP bioassay has identified several potent rodent carcinogens
(2,10). It is important to identify human cohorts exposed to these
chemicals for epidemiological studies to determine if there is evidence
oftheircarcinogenicity inhumans.
* Use multidisciplinary approaches to focus on important causes of
human cancers based on epidemiological clues. Hopes for prevention of
human cancer are based on the high percentage ofcancers that are envi-
ronmentally related. Yet these hopes are not being realized. Industrial
chemicals are likely to contribute to fewer human cancers than several
other causes, including tobacco, diet, alcoholic beverages, hormones,
UVlight, andviruses. These also representpreventable causes ofhuman
cancer, and a program ofprevention should focus on all environmental
agents. Of course, human cancers probably result from interactions
between multiple etiological factors. Diet appears to represent a major
environmental determinant ofhuman cancer, but the scientific knowl-
edge ofwhat dietary factors are important and how they influence car-
cinogenesis is still rudimentary (11,12). The NTP/NIEHS could make
a major impact in this important area ofcancer prevention. The role of
diet in the NTP bioassay should continue to be addressed (13).
Evaluation ofdietaryfactors forcarcinogenic, co-carcinogenic, and anti-
carcinogenic activity, coupledwith studies ofmechanisms and epidemi-
ology, would have a significant scientific and public health impact. For
example, there is a growing bodyofevidence that consumption offresh
fruitandvegetables is associatedwith adecreased riskofcancer, particu-
larly for the digestive tract and hormone-related cancers (14). Advances
in molecular biology of cancer could rapidly improve our ability to
identifyand understand dietary/nutritional factors in carcinogenesis.
Another area that could benefit considerably from multidisciplinary
approaches is the role ofhormones in cancer (15). Our new initiative in
receptor-mediated pathobiology may provide an example of how to
identifyenvironmental estrogens using an alternative approach (16).
The incidence of non-Hodgkin's lymphoma is increasing faster
than anyother cancer in the United States (12). Increases in this cancer
in agricultural communities suggest apesticide, herbicide, or other agri-
cultural exposure as a causative factor (18-20). The environmental
cause(s) for this cancer should be better established. Again, interactive
studies using animal models combined with epidemiological investiga-
tions and molecular biology research should be pursued.
* Develop models for important human cancers. Relatively few car-
cinogens have been identified for important human cancers, including
breast, ovarian, prostatic, and colon cancers (15). Development ofbet-
ter animal and cell culture models for these cancers could lead to estab-
lishment ofnewtests forenvironmental causes ofthese cancers.
* Develop and define models for human predisposition and suscepti-
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bilityto cancer. The current regulatory and public health stance is to use
the most sensitive strain ofanimal to predict possible responses of the
most susceptible human subpopulation to a carcinogen, which is a
nonscientific approach to quantitative risk assessment. In the past, the
lack ofscientific knowledge prevented quantitative analyses ofgenetic
predisposition to carcinogenic exposures. This is not as true today. Our
understanding ofthe genetic basis for predispositions is rapidly expand-
ingand should be a major areaofstudy for riskassessment. New mecha-
nistic studies also allow for the development ofbetter animal models for
quantitative assessment ofcarcinogenic risks. Transgenic mice andgenet-
ically selected rodents that recapitulate human predispositions to certain
cancers and other environmentally related diseases should be developed.
Increased efforts should be made to clone and characterize tumor suscep-
tibility genes in mice, such as the Hcs and Pas genes, which are major
determinants ofsusceptibility to liver and lung carcinogenesis in mice
(21,22). This would aid in the evaluation ofresponses at these common
cancersites in the NTP bioassayaswell as possiblyrepresenting newcan-
cersusceptibility genes for liver and lung cancer in humans. The genera-
tion oftransgenic mouse models designed to recapitulate human predis-
positions is now possible, as demonstrated by the p53 knockout mouse
as amodel forLi-Fraumeni syndrome (4,23).
* Determine the role of age in environmentally related diseases.
Aging modifies the response ofan individual to environmental expo-
sures. The NIEHS, in conjunction with the National Institute ofAging
and other agencies, should consider age-related factors in environmental
health as an area ofincreasing concern and should enhance or initiate
research programs in this area.
* Studies ofnonmutagenic mechanisms ofenvironmental chemicals
can lead to better hazard identification and risk assessment. The para-
digm for environmental causes of human diseases, particularly cancer,
has been theabilityofelectrophilic chemicals to damage DNAand cause
mutations (24). This paradigm is considered correct for many chemicals
and should be the basis for the initial evaluation ofchemical hazards as
oudined above. However, nonmutagenic mechanisms are dearly impor-
tant in carcinogenesis as well as other environmentally related diseases.
Mechanistic studies on cell proliferation and cell death, cell-cell interac-
tion and communication, receptor-mediated biological responses, and
regulation ofgene expression, among others, are important for study.
Coordinated and integrated programs to apply this knowledge to car-
cinogen evaluation and riskassessmentshould befurtherestablished.
In conclusion, prevention of environmentally related diseases
remains an important but unachieved public health objective. The NTP
and the NIEHS can better contribute to this public health goal by
encouraging multidisciplinary interactions among scientists involved in
mechanistic studies, carcinogen testing, and epidemiology. Testing for
potential human carcinogens can be further improved by development
ofmechanism-based tests to predict carcinogens using biological activity
and chemical structure.We should constantly question the relevance of
the testing program to humans by determining whether chemicals iden-
tified in rodents have effects in humans. Forexample, it is estimated that
one-third ofall known carcinogens were identified first as carcinogens in
rodents (25-24. Certain human populations areknown to haveelevated
risks to cancer (e.g., farmers), yet the exact etiological agents are
unknown. Rodent carcinogen bioassays in conjunction with epidemio-
logical studies are necessary to identify and prevent these causes ofcan-
cer. Finally, although the mutagenicity ofchemicals is a clearly estab-
lished mechanism ofcancer induction, other mechanisms related to per-
turbations ofsignal transduction pathways remain to be elucidated.
Further insights into how chemicals influence biological systems bynon-
mutagenic mechanisms will lead to a better understanding ofthe impact
ofenvironmental agents on cancer aswell as noncancerendpoints.
J. Carl Barrett
Environmental Carcinogenesis Program
NIEHS
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